Suvretta Capital Management, LLC Coherus Bio Sciences, Inc. Transaction History

Suvretta Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.92 - $16.41 $13.3 Million - $20 Million	-1,218,792 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $11.5 Million - $13.9 Million	729,459 Added 149.07%	1,218,792 $19.5 Million
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $6.2 Million - $8.71 Million	489,333 New	489,333 $7.86 Million
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $3.94 Million - $4.51 Million	-238,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $988,888 - $1.13 Million	56,800 Added 31.33%	238,100 $4.37 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $1.44 Million - $1.92 Million	100,000 Added 123.0%	181,300 $3.24 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $948,771 - $1.83 Million	81,300 New	81,300 $1.32 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.